Thanks very much, Mr. Chair.
Again, as you know, we have an experienced parliamentarian who clearly doesn't know the rules. That being said, he did vote against the Conservative motion to require those people who made disparaging remarks to provide that information to this committee, which didn't happen.
That being said, I think the other thing for folks around this table to consider is this: What's the evidence to say that ephedrine or pseudoephedrine are a significant problem inside the NHP industry and that we need this regulation? Does anybody have any evidence? Does Mr. Naqvi have any evidence? I see that there is no evidence to say that this is necessary.
I would like to ask the experts here from the department this: Are ephedrine and pseudoephedrine being addressed anywhere else by this government? If so, where? What is the likelihood of this substantive subamendment foisted upon the committee playing a significant role in the illegal trade and traffic of ephedrine and pseudoephedrine?